2013

The Swiss coronary stent developer Qvanteq AG closes series B financing round of 4 million Swiss Francs to obtain clinical proof of concept and CE mark

Posted on

Series B financing round Qvanteq AG today announced the successful completion of its series B financing round of 4 million Swiss Francs which has been raised from private investors. The funds will be used to obtain clinical proof of concept in a “First-in-Man” study as well as CE market approval for Qvanteq’s own novel coronary […]